CHANNEL THERAPEUTICS CORPORA
COM SHS · CUSIP 171126105
0
institutional holders
-6 vs Q2 2025
—reported value*
0 new
0 added
0 reduced
5 sold out
net sold ≈ $187.3k (-147.9k shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q3 2025
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q1 2024 | 2 |
| Q2 2024 | 6 |
| Q3 2024 | 6 |
| Q4 2024 | 5 |
| Q1 2025 | 10 |
| Q2 2025 | 6 |
| Q3 2025 | 0 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q2 2024 | 4 | 1 |
| Q3 2024 | 5 | 3 |
| Q4 2024 | 1 | 3 |
| Q1 2025 | 7 | 1 |
| Q2 2025 | 3 | 7 |
| Q3 2025 | 0 | 5 |
Biggest buyers
| None |
Biggest sellers
| MILLENNIUM MANAGEMENT LLC | Sold out | -136.7k |
| GEODE CAPITAL MANAGEMENT, LLC | Sold out | -10.4k |
| UBS Group AG | Sold out | -652 |
| Tower Research Capital LLC (TRC) | Sold out | -85 |
| BANK OF AMERICA CORP /DE/ | Sold out | -19 |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| Alexandra Wood (Canada) Inc. 13G · passive investor new · filed 2025-01-15 | 9.5% |
| Ikarian Capital, LLC 13G · institution new · filed 2025-02-14 | 7.3% |
Holders, Q3 2025
| Manager | Shares | Change |
|---|